Peptidylprolyl isomerase A pseudogene 86 (PPIAP86)

Peptidylprolyl isomerase A pseudogene 86 (PPIAP86) is classified as a pseudogene in humans and is not known to encode a functional protein[3][4]. Unlike its parental gene, peptidylprolyl isomerase A (PPIA), which encodes cyclophilin A—a well-characterized enzyme involved in protein folding, signaling, and disease processes—PPIAP86 has no evidence of expression, function, or involvement in drug response or disease mechanisms[3][4][1]. Pseudogenes like PPIAP86 may sometimes exert regulatory RNA effects in rare cases, but there is no data supporting any such role for this specific pseudogene. There are related cyclophilin A pseudogenes with regulatory roles described in cancer biology (e.g., PPIAP22)[7], but PPIAP86 itself is not studied or documented in this context. Accordingly, it is not a therapeutic target, receptor, enzyme, or biomarker, and there are no drugs or safety concerns related to it. Key findings: - PPIAP86 is a pseudogene based on NCBI and GeneCards annotation[3][4]. - No evidence for protein expression, biological function, disease association, or drug interaction exists for PPIAP86[3][4]. - It should not be considered a therapeutic target, and if used as such, the target assignment would be incorrect.

Other names

PPIAP86